Interactive Brokers: Volatility Is Supercharging Commercial Momentum — Positive
IBKR Seeking Alpha — May 26, 2025IBKR capitalizes on market volatility, with Trump's tariff announcement sparking surges in trading activity, DARTs, and new account growth. Q1 2025 results exceeded expectations: adjusted net revenues up 15% YoY, pretax margin at 73%, and strong operating leverage. April metrics highlight momentum: 3.7 million accounts (+32% YoY), 3.8 million DARTs (+63% YoY), and $133 billion in client credit balances.

AGNC Vs STWD: Which mREIT Has Stronger Income Potential? — Positive
AGNC STWD Zacks Investment Research — May 26, 2025AGNC Investment's proactive hedging, stable Agency MBS income and 16.29% dividend yield give it an edge over Starwood Property.

NIO vs. TSLA: Which EV Stock Has More Charge for the Future? — Negative
NIO TSLA Zacks Investment Research — May 26, 2025NIO and Tesla face challenges, but one seems better placed now. We break down what drives each and which EV stock deserves your attention today.

UAL Seals Pivotal Deal With Flight Attendants, Uplifts Outlook — Positive
UAL Zacks Investment Research — May 26, 2025United Airlines reaches a tentative deal with flight attendants, offering top-tier pay, bonuses and scheduling gains for 28,000 crew over five years.

MRK Down 21% YTD: Should You Buy, Hold or Sell the Stock? — Negative
MRK Zacks Investment Research — May 26, 2025Merck stock lags industry as Keytruda dependency, Gardasil woes in China, and tariff risks cloud outlook despite pipeline strength and new launches.

Transaction in Own Shares 26 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 26 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 26/05/2025 399,111 €29.3700 €29.1950 €29.2828 XAMS EUR 26/05/2025 155,116 €29.3700 €29.2000 €29.2831 CBOE DXE EUR 26/05/2025 60,773 €29.3700 €29.2000 €29.2902 TQEX EUR These share purchases form part …

Wall Street analysts are holding a slightly bearish outlook on Lucid's (NASDAQ: LCID) stock over the next year as the equity continues to experience increased volatility.

Amazon Stock (NASDAQ: AMZN) Price Prediction and Forecast 2025-2030 for May 26 — Positive
AMZN 24/7 Wall Street — May 26, 2025Shares of Amazon.com Inc. (NASDAQ: AMZN) slipped by 0.3% over the past five trading sessions, briefly muting a rally that's seen the stock gain 11.58% over the past month.

Palantir Technologies (NASDAQ: PLTR) Price Prediction and Forecast 2025-2030 for May 26 — Negative
PLTR 24/7 Wall Street — May 26, 2025Shares of Palantir Technologies Inc. (NASDAQ:PLTR) were mostly flat over the past five trading sessions, falling by 0.10%.

Best Natural and Organic Food Stocks to Keep an Eye On in 2025 — Positive
BYND GIS SFM UNFI Zacks Investment Research — May 26, 2025Sprouts Farmers, United Natural, Beyond Meat and General Mills are betting big on organic, clean-label foods and redefining what's healthy on store shelves.

Dycom Jumps 39% in 3 Months: Should You Buy, Sell or Hold the Stock? — Positive
DY Zacks Investment Research — May 26, 2025DY gains from fiber-to-the-home programs and hyperscaler projects, offsetting macro and tariff headwinds with strong long-term growth visibility.

Merck (NYSE:MRK) stock has experienced a significant 22% decline this year, sharply underperforming the broader S&P 500 index, which is down only 1%. This downturn can be attributed to several factors: a lowered guidance for 2025 and growing concerns about the long-term growth prospects of its blockbuster drugs, Keytruda and Gardasil.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DV — Neutral
DV Accesswire — May 26, 2025NEW YORK CITY, NY / ACCESS Newswire / May 25, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than July 21, 2025.

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Open Lending Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - LPRO — Neutral
LPRO Accesswire — May 26, 2025NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: New York, N.Y., May 26, 2025.

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI — Neutral
TMCI Accesswire — May 26, 2025NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ:TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST — Neutral
WST Accesswire — May 26, 2025NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE:WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Gorilla Pops 14.6% on Buyback Completion: Should You Buy GRRR Now? — Positive
GRRR Zacks Investment Research — May 26, 2025GRRR rallies after completing $5.4M in buybacks and lifting insider ownership to 20%, with 2025 growth and margins tracking higher.

Wix Acquires Hour One to Boost Generative AI and Drive Innovation — Positive
WIX Zacks Investment Research — May 26, 2025WIX acquires Hour One to scale AI media creation, boost immersive web design and cut reliance on third parties for front-end innovation.

Cautious Optimism in Gap's Pre-Q1 Earnings: Buy or Hold for Now? — Positive
GAP Zacks Investment Research — May 26, 2025GAP expects modest Q1 growth, margin expansions and brand momentum, with cost controls helping offset macro and tariff headwinds in the upcoming report.

CrowdStrike: Don't Chase, As Q1 Results Are Unlikely To Be Stellar — Positive
CRWD Seeking Alpha — May 26, 2025CrowdStrike has outperformed both the market and cybersecurity peers quite handsomely this year, with the sustainability of this alpha likely to be dictated by Q1 earnings on the 3rd of June. The pace of sales growth is expected to dip even further, but the decline in new ARR may not be as bad as what was seen in H2-25. CRWD is due to face pressure on the operational margin front, as it ramps up investments and incurs one-off costs.
